The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact

ID Corner: Lefamulin (Xenleta) for community-acquired bacterial pneumonia (CABP)

by Stephanie Londre, PharmD

"According to the World Health Organization, lower respiratory disease is the fourth leading cause of death worldwide. At the same time, antibiotic resistance has emerged in several common pathogens that cause community-acquired bacterial pneumonia (CABP). The general treatment modalities used for CABP, according to the 2019 CABP Infectious Diseases Society of American (IDSA) guideline, are beta-lactams, doxycycline, macrolides, or fluoroquinolones, depending on CABP severity and setting (outpatient versus inpatient)."
​
Keywords: Methicillin-Resistant Staphylococcus aureus, Moxifloxacin, Linezolid, Doxycycline, Anti-Bacterial Agents, Fluoroquinolones
 Macrolides, beta-Lactams, Pharmaceutical Preparations, Incidence, Benchmarking, United States Food and Drug Administration, Injection Site Reaction, Influenza, Human, Intention to Treat Analysis, Liver Function Tests, Drug Resistance, Microbial, Communicable Diseases, Diarrhea, Nausea, World Health Organization

​Download PDF 

2021 July/August Table of Contents 

The Journal of the Pharmacy Society of Wisconsin


Past Issues

2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

thejournal@pswi.org
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact